Concentra Group Holdings Parent, Inc.(CON)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #392 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CON Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Concentra Group Holdings Parent, Inc. (CON), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CON at 68.9/100 on a 32-signal composite quality model, placing it at rank #392 of 2,879 stocks — the top 25% of the AI-ranked universe. CON scores in the top quartile across institutional flow (91.9), revenue growth (79.9), balance sheet strength (76.3). Based on the latest XBRL financial filings (Q1 2026), Concentra Group Holdings Parent, Inc. reports quarterly revenue of $569.6M, net income of $50.5M, an operating margin of 16.8%. Top institutional holders of CON by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CON trades on the NYSE exchange and files with the SEC under CIK 2014596. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Concentra Group Holdings Parent, Inc. directly from SEC EDGAR. Concentra Group Holdings Parent, Inc.'s 13F Pro composite quality score has ranged between 8 and 69 since 2025, currently 68.9 — an improving long-term trajectory across 40 quarterly and live scoring snapshots.
What's Driving CON's Business? Latest 10-Q Breakdown
AI-extracted from Concentra Group Holdings Parent, Inc.'s 10-Q filed 2026-05-07 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Concentra reported Q1 revenue of $569.6M, up 13.7% YoY, driven by 6.7% organic visit growth, 3.1% higher revenue per visit, and the Pivot acquisition adding 240+ onsite clinics.
Biggest Revenue Drivers
Total revenue: $569.6M+13.7% YoY
Workers' compensation VPD volume increased 9.6%, employer services VPD volume increased 4.8%, with revenue per visit up 3.1%.
Includes Concentra Telemed, Pharmacy, and Medical Compliance Administration services.
Largest Expense Items
70.1% of revenue vs. 71.3% prior year; improved due to staffing efficiencies relative to 13.7% revenue growth.
9.7% of revenue; increase driven by separation costs from Select and operating as standalone public company.
Increased due to growth investments in 2025.
Slight increase due to $102.1M incremental term loan added in March 2025.
Watch Items from the Filing
- California whistleblower qui tam lawsuit unsealed Nov 2025 alleging false physical therapy claims to insurers; DOJ investigation ongoing since 2021 into physical therapy billing practices; timing and outcome unpredictable.
- Perry Johnson data breach affecting ~4M patients resulted in consolidated class action lawsuit filed Aug 2024; company does not believe material impact but unable to predict outcome.
- Leverage ratio of 3.4x as of Q1 2026, well below covenant maximum of 6.5x, with $434.2M revolving credit availability providing liquidity cushion.
- Accounts receivable increased to $296.5M from $257.9M YTD; however, highly solvent payors (workers' comp, employers, insurers, government) historically result in minimal credit losses.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q1 2026
$569.6M
Net Income
Q1 2026
$50.5M
Free Cash Flow
Q1 2026
$9.9M
Operating Margin
Q1 2026
16.8%
ROIC
Q1 2026
4.8%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+17.7% YoYNet Income
-7.5% YoYOperating Income
+16.1% YoYEPS (Diluted)
-24.9% YoYTotal Assets
+22.5% YoYTotal Debt
+33073.1% YoYOp. Cash Flow
+19.2% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $2.16B +17.7% | $1.84B +6.6% | $1.72B | — |
| Net Income | $166.4M -7.5% | $179.9M +7.9% | $166.7M | — |
| Operating Income | $334.0M +16.1% | $287.6M +11.3% | $258.5M | — |
| EPS (Diluted) | $1.30 -24.9% | $1.73 +8.1% | $1.60 | — |
| Total Assets | $2.86B +22.5% | $2.33B +1.6% | $2.30B | — |
| Total Debt | $1.57B +33073.1% | $4.7M | — | — |
| Operating Cash Flow | $279.4M +19.2% | $234.3M -14.6% | $274.3M | — |
AI Insight: CON Financial Trends
Revenue grew 16% from Q3 2024 to Q1 2026, but Q4 2025 pullback and operating leverage compression signal margin pressure ahead.
• Revenue expanded from $490M (Q3 2024) to $570M (Q1 2026), +16% growth over 6 quarters.
• Operating margin compressed from 17.6% (Q3 2024) to 16.8% (Q1 2026); Q4 2025 dipped to 13.0%.
• Debt stable near $1.6B since Q1 2025; equity grew 52% from Q3 2024 ($278M) to Q1 2026 ($425M).
⚠ Q4 2025 revenue fell 6% QoQ to $539M; Q1 2026 recovery to $570M unclear if sustainable.
⚠ Operating cash flow volatile: $12M (Q1 2025), $88M (Q2 2025), $61M (Q3 2025), $119M (Q4 2025), $21M (Q1 2026).
AI Insight: CON Ratio Trends
Operating margin and ROIC stabilized at healthy levels in Q1 2026, but Q4 seasonal weakness and volatile profitability metrics warrant caution.
• OpMargin recovered to 16.8% in Q1 2026 from Q4 2025's 12.9% trough, tracking prior-year Q1 strength of 16.0%.
• ROIC improved to 19.1% in Q1 2026 from 14.2% in Q4 2025, exceeding TTM level of 17.5%.
• Leverage (D/E) declined steadily from 5.34 in Q3 2024 to 3.71 in Q1 2026, showing improved balance-sheet discipline.
⚠ Q4 2025 saw sharp profitability drops: OpMargin fell to 12.9%, NPM to 6.4%, ROIC to 14.2%—consistent Q4 weakness pattern.
⚠ Q4 2024 ROIC spiked anomalously to 82.7% with D/E near zero—likely one-off; volatility signals inconsistent earnings quality.
Get alerted when CON's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Concentra Group Holdings Parent, Inc. including:
Top Institutional Holders of CON
BlackRock, Inc.
$366.1M17,067,350 shVANGUARD PORTFOLIO MANAGEMENT LLC
$144.5M6,738,925 shVANGUARD CAPITAL MANAGEMENT LLC
$109.3M5,095,516 shSTATE STREET CORP
$98.7M4,602,825 shBARROW HANLEY MEWHINNEY & STRAUSS LLC
$68.8M3,207,304 shDIMENSIONAL FUND ADVISORS LP
$66.6M3,107,254 shGEODE CAPITAL MANAGEMENT, LLC
$62.9M2,933,174 shPRINCIPAL FINANCIAL GROUP INC
$57.2M2,668,512 shInvesco Ltd.
$57.2M2,667,194 shJENNISON ASSOCIATES LLC
$46.6M2,172,291 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $366.1M | 17,067,350 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $144.5M | 6,738,925 |
| VANGUARD CAPITAL MANAGEMENT LLC | $109.3M | 5,095,516 |
| STATE STREET CORP | $98.7M | 4,602,825 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $68.8M | 3,207,304 |
| DIMENSIONAL FUND ADVISORS LP | $66.6M | 3,107,254 |
| GEODE CAPITAL MANAGEMENT, LLC | $62.9M | 2,933,174 |
| PRINCIPAL FINANCIAL GROUP INC | $57.2M | 2,668,512 |
| Invesco Ltd. | $57.2M | 2,667,194 |
| JENNISON ASSOCIATES LLC | $46.6M | 2,172,291 |
More Healthcare Companies
View all Healthcare →Put CON on your watchlist
Track score changes the day Concentra Group Holdings Parent, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CON a good stock to buy?
13F Pro's AI-powered analysis of Concentra Group Holdings Parent, Inc. (CON) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CON are available on the CON stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CON?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CON. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Concentra Group Holdings Parent, Inc.'s investment landscape.